Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease.
Leuk Lymphoma
; 48(3): 623-4, 2007 Mar.
Article
in En
| MEDLINE
| ID: mdl-17454609
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Steroids
/
Lymphoma, B-Cell
/
Graft vs Host Disease
/
Immunosuppressive Agents
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2007
Document type:
Article